Success Metrics

Clinical Success Rate
84.6%

Based on 11 completed trials

Completion Rate
85%(11/13)
Active Trials
0(0%)
Results Posted
45%(5 trials)
Terminated
2(15%)

Phase Distribution

Ph phase_2
1
8%
Ph not_applicable
12
92%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
N/ANon-phased studies
12(92.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(11)
Terminated(2)

Detailed Status

Completed11
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
84.6%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (7.7%)
N/A12 (92.3%)

Trials by Status

terminated215%
completed1185%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
OTHER
Total Trials
13